olopatadine hydrochloride
NDC 45802-104 · Padagis Israel Pharmaceuticals Ltd
Packages
45802-104-01 — 1 BOTTLE in 1 CARTON (45802-104-01) / 240 SPRAY in 1 BOTTLE
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
24208-617 — OLOPATADINE HYDROCHLORIDE, 24208-966 — Olopatadine Hydrochloride Ophthalmic Solution, 24208-967 — OLOPATADINE HYDROCHLORIDE, 30142-026 — OLOPATADINE HYDROCHLORIDE, 30142-064 — OLOPATADINE HYDROCHLORIDE, 37808-045 — Olopatadine Hydrochloride Ophthalmic Solution, 43598-764 — Olopatadine Hydrochloride Ophthalmic, 43598-765 — Olopatadine Hydrochloride Ophthalmic, 43598-826 — Olopatadine Hydrochloride Ophthalmic, 43598-827 — Olopatadine Hydrochloride Ophthalmic, 46122-671 — OLOPATADINE HYDROCHLORIDE, 46122-672 — OLOPATADINE HYDROCHLORIDE, 46122-823 — Olopatadine Hydrochloride ophthalmic, 46122-824 — OLOPATADINE HYDROCHLORIDE, 46708-709 — olopatadine hydrochloride, 46708-710 — olopatadine hydrochloride, 50090-5613 — OLOPATADINE HYDROCHLORIDE, 50090-6341 — OLOPATADINE HYDROCHLORIDE, 50090-7959 — Olopatadine, 51316-567 — olopatadine hydrochloride ophthalmic, +93 more
Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels